WAY-652509 is a potent casein kinase 1δ (CK1δ/CK15) inhibitor for studies related to neurodegenerative diseases such as Alzheimer's disease.
Benzalkonium chloride is a cationic surface-acting agent containing the quaternary ammonium group
Benzalkonium chloride is a cationic surface-acting agent containing the quaternary ammonium group
FPFT-2216 is a ''molecular glue'' compound that degrades phosphatidiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3) and casein kinase 1α (CK1α). It can be used for cancer and inflammatory disease research.
FPFT-2216 is a ''molecular glue'' compound that degrades phosphatidiesterase 6D (PDE6D), zinc finger transcription factors Ikaros (IKZF1), Aiolos (IKZF3) and casein kinase 1α (CK1α). It can be used for cancer and inflammatory disease research.
24 norursodeoxycholic acid (nor UDCA) is a C23 homologue of UDCA with shortened side chain, which has effective anti cholestasis, anti-inflammatory and anti fibrosis properties.
Cinnamoylglycine is a human urine metabolite, a glycine conjugate of cinnamic acid and. Cinnamoylglycine is used as a urine marker, which can be used as a marker for colonization of drug resistance after the antibiotic study period.
24 norursodeoxycholic acid (nor UDCA) is a C23 homologue of UDCA with shortened side chain, which has effective anti cholestasis, anti-inflammatory and anti fibrosis properties.
24 norursodeoxycholic acid (nor UDCA) is a C23 homologue of UDCA with shortened side chain, which has effective anti cholestasis, anti-inflammatory and anti fibrosis properties.
Bractoppin is a potent and selective inhibitor of phosphopeptide recognition by the human BRCA1 tandem(t) BRCT domain with IC50 of 74 nM. Bractoppin diminishes BRCA1 recruitment to DNA breaks, in turn suppressing damage-induced G2 arrest and assembly of the recombinase, RAD51.